Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01020890
NCT01020890
Completed
Not Applicable

A Cross-sectional Study on the Prevalence of GERD in Primary Care Patients With Upper GI Symptoms Using the GERD-Q. The Bulgarian GERD-Q Study

AstraZeneca1 site in 1 country2,210 target enrollmentNovember 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGastroesophageal Reflux Disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastroesophageal Reflux Disease
Sponsor
AstraZeneca
Enrollment
2210
Locations
1
Status
Completed
Last Updated
15 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to provide data on the gastroesophageal reflux disease (GERD) prevalence as percentage of patients with upper gastrointestinal (GI) symptoms that are identified with GERD using the Gerd-Q Questionnaire.

Registry
clinicaltrials.gov
Start Date
November 2009
End Date
April 2010
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with upper gastrointestinal symptoms

Exclusion Criteria

  • •History of oesophageal, gastric or duodenal surgery
  • •Current treatment with antiinflammatory drugs, including OTC
  • •Current treatment with proton pump inhibitors ang H2-blockers

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in EgyptPatients With Upper Gastro-intestinal Symptoms
NCT01635959AstraZeneca3,170
Completed
Not Applicable
Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQGastroesophageal Reflux Disease
NCT00914342AstraZeneca889
Completed
Not Applicable
A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in GreeceGastroesophageal Reflux Disease
NCT01215305AstraZeneca600
Completed
Not Applicable
Impact of GERD on Daily Life (NIS)GERD
NCT00545883AstraZeneca2,001
Unknown
Not Applicable
Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD)Gastroesophageal Reflux Disease
NCT04094402Scandinavia Pharma1,500